These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 38274225)

  • 21. Low-density lipoprotein docosahexaenoic acid nanoparticles induce ferroptotic cell death in hepatocellular carcinoma.
    Ou W; Mulik RS; Anwar A; McDonald JG; He X; Corbin IR
    Free Radic Biol Med; 2017 Nov; 112():597-607. PubMed ID: 28893626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of ferroptosis-related genes for overall survival prediction in hepatocellular carcinoma.
    Luo L; Yao X; Xiang J; Huang F; Luo H
    Sci Rep; 2022 Jun; 12(1):10007. PubMed ID: 35705729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver Cancer.
    Cheu JW; Lee D; Li Q; Goh CC; Bao MH; Yuen VW; Zhang MS; Yang C; Chan CY; Tse AP; Sit GF; Liu CX; Ng IO; Wong CM; Wong CC
    Cell Mol Gastroenterol Hepatol; 2023; 16(1):133-159. PubMed ID: 36893885
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Li Y; Zhang J; Zhang K; Chen Y; Wang W; Chen H; Zou Z; Li Y; Dai M
    Front Oncol; 2022; 12():693395. PubMed ID: 35321425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rhamnazin Inhibits Hepatocellular Carcinoma Cell Aggressiveness in Vitro via Glutathione Peroxidase 4-Dependent Ferroptosis.
    Mei F; Liu Y; Zheng S
    Tohoku J Exp Med; 2022 Sep; 258(2):111-120. PubMed ID: 35896364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Excessive SOX8 reprograms energy and iron metabolism to prime hepatocellular carcinoma for ferroptosis.
    Yang X; Gu C; Cai J; Li F; He X; Luo L; Xiao W; Hu B; Hu J; Qian H; Ren S; Zhang L; Zhu X; Yang L; Yang J; Yang Z; Zheng Y; Huang X; Wang Z
    Redox Biol; 2024 Feb; 69():103002. PubMed ID: 38142583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COMMD10 inhibits HIF1α/CP loop to enhance ferroptosis and radiosensitivity by disrupting Cu-Fe balance in hepatocellular carcinoma.
    Yang M; Wu X; Hu J; Wang Y; Wang Y; Zhang L; Huang W; Wang X; Li N; Liao L; Chen M; Xiao N; Dai Y; Liang H; Huang W; Yuan L; Pan H; Li L; Chen L; Liu L; Liang L; Guan J
    J Hepatol; 2022 May; 76(5):1138-1150. PubMed ID: 35101526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ferroptosis-related small-molecule compounds in cancer therapy: Strategies and applications.
    Yin L; Liu P; Jin Y; Ning Z; Yang Y; Gao H
    Eur J Med Chem; 2022 Dec; 244():114861. PubMed ID: 36332549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-Administration of iRGD with Sorafenib-Loaded Iron-Based Metal-Organic Framework as a Targeted Ferroptosis Agent for Liver Cancer Therapy.
    Liu X; Zhu X; Qi X; Meng X; Xu K
    Int J Nanomedicine; 2021; 16():1037-1050. PubMed ID: 33603367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
    Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
    Front Immunol; 2021; 12():719175. PubMed ID: 34603293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel sesquiterpene lactone fraction from Eupatorium chinense L. suppresses hepatocellular carcinoma growth by triggering ferritinophagy and mitochondrial damage.
    Zhu ZH; Xu XT; Shen CJ; Yuan JT; Lou SY; Ma XL; Chen X; Yang B; Zhao HJ
    Phytomedicine; 2023 Apr; 112():154671. PubMed ID: 36773432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steroidal saponin SSPH I induces ferroptosis in HepG2 cells via regulating iron metabolism.
    Huang D; Dong X; Li J; Chen Y; Zhou Y; Chen Q; Sun Y
    Med Oncol; 2023 Mar; 40(5):132. PubMed ID: 36977862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma.
    Li ZJ; Dai HQ; Huang XW; Feng J; Deng JH; Wang ZX; Yang XM; Liu YJ; Wu Y; Chen PH; Shi H; Wang JG; Zhou J; Lu GD
    Acta Pharmacol Sin; 2021 Feb; 42(2):301-310. PubMed ID: 32699265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Ferroptosis-related molecular model and immune subtypes of hepatocellular carcinoma for individual therapy.
    Long S; Chen Y; Wang Y; Yao Y; Xiao S; Fu K
    Cancer Med; 2023 Jan; 12(2):2134-2147. PubMed ID: 35841206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Research mechanisms of and pharmaceutical treatments for ferroptosis in liver diseases.
    Yu J; Wang JQ
    Biochimie; 2021 Jan; 180():149-157. PubMed ID: 33166595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breaking the Barriers of Therapy Resistance: Harnessing Ferroptosis for Effective Hepatocellular Carcinoma Therapy.
    Lv X; Lan G; Zhu L; Guo Q
    J Hepatocell Carcinoma; 2024; 11():1265-1278. PubMed ID: 38974015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation.
    Bekric D; Ocker M; Mayr C; Stintzing S; Ritter M; Kiesslich T; Neureiter D
    Cancers (Basel); 2022 Apr; 14(7):. PubMed ID: 35406596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sorafenib triggers ferroptosis via inhibition of HBXIP/SCD axis in hepatocellular carcinoma.
    Zhang L; Li XM; Shi XH; Ye K; Fu XL; Wang X; Guo SM; Ma JQ; Xu FF; Sun HM; Li QQ; Zhang WY; Ye LH
    Acta Pharmacol Sin; 2023 Mar; 44(3):622-634. PubMed ID: 36109580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NeuroD1-GPX4 signaling leads to ferroptosis resistance in hepatocellular carcinoma.
    Huang P; Duan W; Ruan C; Wang L; Hosea R; Wu Z; Zeng J; Wu S; Kasim V
    PLoS Genet; 2023 Dec; 19(12):e1011098. PubMed ID: 38134213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells.
    Sun X; Ou Z; Chen R; Niu X; Chen D; Kang R; Tang D
    Hepatology; 2016 Jan; 63(1):173-84. PubMed ID: 26403645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.